Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 528

1.

Candida biofilm production is associated with higher mortality in patients with candidaemia.

Vitális E, Nagy F, Tóth Z, Forgács L, Bozó A, Kardos G, Majoros L, Kovács R.

Mycoses. 2020 Jan 13. doi: 10.1111/myc.13049. [Epub ahead of print]

PMID:
31943428
2.

Exercise Effects on Multiple Sclerosis Quality of Life and Clinical-Motor Symptoms.

Tollár J, Nagy F, Tóth BE, Török K, Szita K, Csutorás B, Moizs M, Hortobágyi T.

Med Sci Sports Exerc. 2019 Dec 23. doi: 10.1249/MSS.0000000000002228. [Epub ahead of print]

PMID:
31876670
3.

[The occurrence of neuroinvasive symptoms caused by the West Nile virus at an emergency center].

Koch M, Török KT, Nagy F, Soós V, Pozsgai É, Lelovics Z, Nagy A, Varga C.

Orv Hetil. 2019 Dec;160(51):2026-2035. doi: 10.1556/650.2019.31575. Review. Hungarian.

PMID:
31838862
4.

Thermal reversion of plant phytochromes.

Klose C, Nagy F, Schäfer E.

Mol Plant. 2019 Dec 5. pii: S1674-2052(19)30400-9. doi: 10.1016/j.molp.2019.12.004. [Epub ahead of print] Review.

PMID:
31812690
5.

Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study.

Bor R, Fábián A, Matuz M, Szepes Z, Farkas K, Miheller P, Szamosi T, Vincze Á, Rutka M, Szántó K, Bálint A, Nagy F, Milassin Á, Tóth T, Zsigmond F, Bajor J, Müllner K, Lakner L, Papp M, Salamon Á, Horváth G, Sarang K, Schäfer E, Sarlós P, Palatka K, Molnár T.

Expert Opin Biol Ther. 2020 Feb;20(2):205-213. doi: 10.1080/14712598.2020.1699529. Epub 2019 Dec 6.

PMID:
31782939
6.

Comparative biocompatibility and antimicrobial studies of sorbic acid derivates.

Nemes D, Kovács R, Nagy F, Tóth Z, Herczegh P, Borbás A, Kelemen V, Pfliegler WP, Rebenku I, Hajdu PB, Fehér P, Ujhelyi Z, Fenyvesi F, Váradi J, Vecsernyés M, Bácskay I.

Eur J Pharm Sci. 2020 Feb 15;143:105162. doi: 10.1016/j.ejps.2019.105162. Epub 2019 Nov 20.

7.

"Fishing and Hunting"-Selective Immobilization of a Recombinant Phenylalanine Ammonia-Lyase from Fermentation Media.

Sánta-Bell E, Molnár Z, Varga A, Nagy F, Hornyánszky G, Paizs C, Balogh-Weiser D, Poppe L.

Molecules. 2019 Nov 15;24(22). pii: E4146. doi: 10.3390/molecules24224146.

8.

Light Triggers the miRNA-Biogenetic Inconsistency for De-etiolated Seedling Survivability in Arabidopsis thaliana.

Choi SW, Ryu MY, Viczián A, Jung HJ, Kim GM, Arce AL, Achkar NP, Manavella P, Dolde U, Wenkel S, Molnár A, Nagy F, Cho SK, Yang SW.

Mol Plant. 2019 Oct 31. pii: S1674-2052(19)30337-5. doi: 10.1016/j.molp.2019.10.011. [Epub ahead of print]

PMID:
31678531
9.

A Deep Learning-Based Approach for High-Throughput Hypocotyl Phenotyping.

Dobos O, Horvath P, Nagy F, Danka T, Viczián A.

Plant Physiol. 2019 Dec;181(4):1415-1424. doi: 10.1104/pp.19.00728. Epub 2019 Oct 21.

PMID:
31636105
10.

Differential phosphorylation of the N-terminal extension regulates phytochrome B signaling.

Viczián A, Ádám É, Staudt AM, Lambert D, Klement E, Romero Montepaone S, Hiltbrunner A, Casal J, Schäfer E, Nagy F, Klose C.

New Phytol. 2020 Feb;225(4):1635-1650. doi: 10.1111/nph.16243. Epub 2019 Nov 7.

PMID:
31596952
11.

In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.

Tóth Z, Forgács L, Locke JB, Kardos G, Nagy F, Kovács R, Szekely A, Borman AM, Majoros L.

J Antimicrob Chemother. 2019 Dec 1;74(12):3505-3510. doi: 10.1093/jac/dkz390.

12.

A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary.

Papp V, Iljicsov A, Rajda C, Magyari M, Koch-Henriksen N, Petersen T, Jakab G, Deme I, Nagy F, Imre P, Lohner Z, Kovács K, Birkás AJ, Köves Á, Rum G, Nagy Z, Kerényi L, Vécsei L, Bencsik K, Jobbágy Z, Diószeghy P, Horváth L, Galántai G, Kasza J, Molnár G, Simó M, Sátori M, Rózsa C, Ács P, Berki T, Lovas G, Komoly S, Illes Z.

Eur J Neurol. 2020 Feb;27(2):308-317. doi: 10.1111/ene.14079. Epub 2019 Sep 30.

PMID:
31465603
13.

Physiological and Transcriptional Responses of Candida parapsilosis to Exogenous Tyrosol.

Jakab Á, Tóth Z, Nagy F, Nemes D, Bácskay I, Kardos G, Emri T, Pócsi I, Majoros L, Kovács R.

Appl Environ Microbiol. 2019 Oct 1;85(20). pii: e01388-19. doi: 10.1128/AEM.01388-19. Print 2019 Oct 15.

PMID:
31399405
14.

Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.

Kovács R, Nagy F, Tóth Z, Bozó A, Balázs B, Majoros L.

Lett Appl Microbiol. 2019 Oct;69(4):271-278. doi: 10.1111/lam.13204. Epub 2019 Aug 23.

PMID:
31385615
15.

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis.

Prépost E, Tóth Z, Perlin DS, Gesztelyi R, Kardos G, Kovács R, Nagy F, Forgács L, Majoros L.

Infect Drug Resist. 2019 Jul 1;12:1805-1814. doi: 10.2147/IDR.S198764. eCollection 2019.

16.

Differential UVR8 Signal across the Stem Controls UV-B-Induced Inflorescence Phototropism.

Vanhaelewyn L, Viczián A, Prinsen E, Bernula P, Serrano AM, Arana MV, Ballaré CL, Nagy F, Van Der Straeten D, Vandenbussche F.

Plant Cell. 2019 Sep;31(9):2070-2088. doi: 10.1105/tpc.18.00929. Epub 2019 Jul 9.

PMID:
31289115
17.

[18F-fluoro-deoxy-glucose positron emission tomography/computer tomography (18F-FDG-PET/CT) imaging in cardiology].

Besenyi Z, Nagy FT, Sághy L, Pávics L.

Orv Hetil. 2019 Jun;160(26):1015-1024. doi: 10.1556/650.2019.31414. Review. Hungarian.

PMID:
31230470
18.

Farnesol increases the activity of echinocandins against Candida auris biofilms.

Nagy F, Tóth Z, Daróczi L, Székely A, Borman AM, Majoros L, Kovács R.

Med Mycol. 2019 May 25. pii: myz057. doi: 10.1093/mmy/myz057. [Epub ahead of print]

PMID:
31127836
19.

Diverse Exercises Similarly Reduce Older Adults' Mobility Limitations.

Tollár J, Nagy F, Moizs M, Tóth BE, Sanders LMJ, Hortobágyi T.

Med Sci Sports Exerc. 2019 Sep;51(9):1809-1816. doi: 10.1249/MSS.0000000000002001.

PMID:
30973482
20.

[Periodontal disease, a risk factor for atherosclerotic cardiovascular disease].

Gheorghita D, Eördegh G, Nagy F, Antal M.

Orv Hetil. 2019 Mar;160(11):419-425. doi: 10.1556/650.2019.31301. Review. Hungarian.

PMID:
30852909
21.

Activity painting: PET images of freely defined activity distributions applying a novel phantom technique.

Forgacs A, Kallos-Balogh P, Nagy F, Krizsan AK, Garai I, Tron L, Dahlbom M, Balkay L.

PLoS One. 2019 Jan 25;14(1):e0207658. doi: 10.1371/journal.pone.0207658. eCollection 2019.

22.

Detection of myocardial inflammation by 18F-FDG-PET/CT in patients with systemic sclerosis without cardiac symptoms: a pilot study.

Besenyi Z, Ágoston G, Hemelein R, Bakos A, Nagy FT, Varga A, Kovács L, Pávics L.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):88-96. Epub 2018 Dec 7.

23.

[Transfer of care of adolescent inflammatory bowel disease patients without longitudinal transition. Lesson from 10 years experiences].

Szántó K, Szűcs D, Vass N, Várkonyi Á, Bálint A, Bor R, Fábián A, Milassin Á, Rutka M, Szepes Z, Nagy F, Molnár T, Farkas K.

Orv Hetil. 2018 Nov;159(44):1789-1793. doi: 10.1556/650.2018.31198. Hungarian.

PMID:
30392410
24.

Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.

Tóth Z, Kardos T, Kovács R, Kardos G, Nagy F, Prépost E, Barta Z, Takacs I, Majoros L.

Mycopathologia. 2018 Dec;183(6):905-912. doi: 10.1007/s11046-018-0302-5. Epub 2018 Oct 31.

PMID:
30382508
25.

Vastly Different Exercise Programs Similarly Improve Parkinsonian Symptoms: A Randomized Clinical Trial.

Tollár J, Nagy F, Hortobágyi T.

Gerontology. 2019;65(2):120-127. doi: 10.1159/000493127. Epub 2018 Oct 26.

PMID:
30368495
26.

Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.

Nagy F, Tóth Z, Bozó A, Czeglédi A, Rebenku I, Majoros L, Kovács R.

Med Mycol. 2018 Oct 18. doi: 10.1093/mmy/myy108. [Epub ahead of print]

PMID:
30339227
27.

Two-Year Agility Maintenance Training Slows the Progression of Parkinsonian Symptoms.

Tollár J, Nagy F, Kovács N, Hortobágyi T.

Med Sci Sports Exerc. 2019 Feb;51(2):237-245. doi: 10.1249/MSS.0000000000001793.

PMID:
30303934
28.

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort.

Bálint A, Rutka M, Kolar M, Bortlik M, Duricova D, Hruba V, Lukas M, Mitrova K, Malickova K, Lukas M, Szepes Z, Nagy F, Palatka K, Lovas S, Végh Z, Kürti Z, Csontos Á, Miheller P, Nyári T, Bor R, Milassin Á, Fábián A, Szántó K, Lakatos PL, Molnár T, Farkas K.

Expert Opin Biol Ther. 2018 Nov;18(11):1181-1187. doi: 10.1080/14712598.2018.1530758. Epub 2018 Oct 9.

PMID:
30277084
29.

Smart Nanoparticles for Selective Immobilization of Acid Phosphatases.

Nagy F, Tasnádi G, Balogh-Weiser D, Bell E, Hall M, Faber K, Poppe L.

ChemCatChem. 2018 Aug 21;10(16):3490-3499. doi: 10.1002/cctc.201800405. Epub 2018 Jul 17.

30.

ELONGATED HYPOCOTYL 5 mediates blue light signalling to the Arabidopsis circadian clock.

Hajdu A, Dobos O, Domijan M, Bálint B, Nagy I, Nagy F, Kozma-Bognár L.

Plant J. 2018 Dec;96(6):1242-1254. doi: 10.1111/tpj.14106. Epub 2018 Oct 27.

31.

Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.

Szántó K, Nyári T, Bálint A, Bor R, Milassin Á, Rutka M, Fábián A, Szepes Z, Nagy F, Molnár T, Farkas K.

PLoS One. 2018 Jul 30;13(7):e0200824. doi: 10.1371/journal.pone.0200824. eCollection 2018.

32.

Interaction between Different Pharmaceutical Excipients in Liquid Dosage Forms-Assessment of Cytotoxicity and Antimicrobial Activity.

Nemes D, Kovács R, Nagy F, Mező M, Poczok N, Ujhelyi Z, Pető Á, Fehér P, Fenyvesi F, Váradi J, Vecsernyés M, Bácskay I.

Molecules. 2018 Jul 23;23(7). pii: E1827. doi: 10.3390/molecules23071827.

33.

Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.

Kardos T, Kovács R, Kardos G, Varga I, Bozó A, Tóth Z, Nagy F, Majoros L.

J Chemother. 2018 Jul;30(4):233-239. doi: 10.1080/1120009X.2018.1487150. Epub 2018 Jul 20.

PMID:
30025501
34.

A High-Intensity Multicomponent Agility Intervention Improves Parkinson Patients' Clinical and Motor Symptoms.

Tollár J, Nagy F, Kovács N, Hortobágyi T.

Arch Phys Med Rehabil. 2018 Dec;99(12):2478-2484.e1. doi: 10.1016/j.apmr.2018.05.007. Epub 2018 Jun 7.

PMID:
29886075
35.

[Childhood sporadic type of hemiplegic migraine with arteria cerebri media hypoperfusion].

Nagy C, Bajzik G, Skobrák A, Csorba E, Lajtai A, Balogh G, Nagy F, Vajda Z.

Ideggyogy Sz. 2017 Sep 30;70(9-10):343-348. doi: 10.18071/isz.70.0343. Hungarian.

PMID:
29870626
36.

The Use of Complementary and Alternative Medicine Is Less Frequent in Patients with Inflammatory Bowel Disease Than in Patients with Other Chronic Gastrointestinal Disorders.

Fábián A, Rutka M, Ferenci T, Bor R, Bálint A, Farkas K, Milassin Á, Szántó K, Lénárt Z, Nagy F, Szepes Z, Molnár T.

Gastroenterol Res Pract. 2018 Apr 3;2018:9137805. doi: 10.1155/2018/9137805. eCollection 2018.

37.

Comparison of Platelet Function Guided Versus Unguided Treatment With P2Y12 Inhibitors in Patients With Acute Myocardial Infarction (from the Hungarian Myocardial Infarction Registry).

Komócsi A, Aradi D, Szűk T, Nagy GG, Noori E, Ruzsa Z, Kiss RG, Andrássy P, Nagy L, Nagy FT, Lupkovics G, Kőszegi Z, Dézsi CA, Papp E, Molnár Z, Kupó P, Ofner P, Merkely B, Jánosi A.

Am J Cardiol. 2018 May 15;121(10):1129-1137. doi: 10.1016/j.amjcard.2018.01.032. Epub 2018 Feb 13.

38.

Autolytic hydrolases affect sexual and asexual development of Aspergillus nidulans.

Emri T, Vékony V, Gila B, Nagy F, Forgács K, Pócsi I.

Folia Microbiol (Praha). 2018 Sep;63(5):619-626. doi: 10.1007/s12223-018-0601-8. Epub 2018 Mar 30.

PMID:
29603054
39.

[Autoimmune encephalitis: possibilities in the laboratory investigation].

Böröcz K, Hayden Z, Mészáros V, Csizmadia Z, Farkas K, Kellermayer Z, Balogh P, Nagy F, Berki T.

Orv Hetil. 2018 Jan;159(3):107-112. doi: 10.1556/650.2018.30951. Hungarian.

PMID:
29332416
40.

How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system.

Bálint A, Farkas K, Szepes Z, Nagy F, Szűcs M, Tiszlavicz L, Bor R, Milassin Á, Rutka M, Fábián A, Molnár T.

BMC Gastroenterol. 2018 Jan 8;18(1):7. doi: 10.1186/s12876-017-0725-3.

41.

Extending knowledge of the clinical picture of Balkan adder (Vipera berus bosniensis) envenoming: The first photographically-documented neurotoxic case from South-Western Hungary.

Varga C, Malina T, Alföldi V, Bilics G, Nagy F, Oláh T.

Toxicon. 2018 Mar 1;143:29-35. doi: 10.1016/j.toxicon.2017.12.053. Epub 2018 Jan 2.

PMID:
29305081
42.

[Efficacy of the population-based pilot colorectal screening program. Hungary, Csongrád county, 2015].

Rutka M, Molnár T, Bor R, Farkas K, Fábián A, Győrfi M, Bálint A, Milassin Á, Szűcs M, Tiszlavicz L, Nagy F, Szepes Z.

Orv Hetil. 2017 Oct;158(42):1658-1667. doi: 10.1556/650.2017.30822. Hungarian.

PMID:
29037058
43.

[Neuroacanthocytosis diagnosis with new generation whole exome sequencing].

Hadzsiev K, Szőts M, Fekete A, Balikó L, Boycott K, Nagy F, Melegh B.

Orv Hetil. 2017 Oct;158(42):1681-1684. doi: 10.1556/650.2017.30880. Hungarian.

PMID:
29037056
44.

In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.

Nagy F, Bozó A, Tóth Z, Daróczi L, Majoros L, Kovács R.

Med Mycol. 2018 Jun 1;56(4):493-500. doi: 10.1093/mmy/myx062.

PMID:
28992253
45.

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort.

Gonczi L, Gecse KB, Vegh Z, Kurti Z, Rutka M, Farkas K, Golovics PA, Lovasz BD, Banai J, Bene L, Gasztonyi B, Kristof T, Lakatos L, Miheller P, Nagy F, Palatka K, Papp M, Patai A, Salamon A, Szamosi T, Szepes Z, Toth GT, Vincze A, Szalay B, Molnar T, Lakatos PL.

Inflamm Bowel Dis. 2017 Nov;23(11):1908-1915. doi: 10.1097/MIB.0000000000001237.

PMID:
28922253
46.

Analysis of risk factors - especially different types of plexitis - for postoperative relapse in Crohn's disease.

Milassin Á, Sejben A, Tiszlavicz L, Reisz Z, Lázár G, Szűcs M, Bor R, Bálint A, Rutka M, Szepes Z, Nagy F, Farkas K, Molnár T.

World J Gastrointest Surg. 2017 Jul 27;9(7):167-173. doi: 10.4240/wjgs.v9.i7.167.

47.

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center.

Farkas K, Rutka M, Ferenci T, Nagy F, Bálint A, Bor R, Milassin Á, Fábián A, Szántó K, Végh Z, Kürti Z, Lakatos PL, Szepes Z, Molnár T.

Expert Opin Biol Ther. 2017 Nov;17(11):1325-1332. doi: 10.1080/14712598.2017.1363885. Epub 2017 Aug 18.

PMID:
28819991
48.

Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort.

Bálint A, Rutka M, Végh Z, Kürti Z, Gecse KB, Banai J, Bene L, Gasztonyi B, Kristóf T, Lakatos L, Miheller P, Palatka K, Patai Á, Salamon Á, Szamosi T, Szepes Z, Tóth GT, Vincze Á, Bor R, Milassin Á, Fábián A, Nagy F, Kolar M, Bortlik M, Duricova D, Hruba V, Lukas M, Mitrova K, Malickova K, Lukas M, Lakatos PL, Molnár T, Farkas K.

Expert Opin Drug Saf. 2017 Aug;16(8):885-890. doi: 10.1080/14740338.2017.1323330. Epub 2017 May 26.

PMID:
28504555
49.

Global brain atrophy and metabolic dysfunction in LGI1 encephalitis: A prospective multimodal MRI study.

Szots M, Blaabjerg M, Orsi G, Iversen P, Kondziella D, Madsen CG, Garde E, Magnusson PO, Barsi P, Nagy F, Siebner HR, Illes Z.

J Neurol Sci. 2017 May 15;376:159-165. doi: 10.1016/j.jns.2017.03.020. Epub 2017 Mar 16.

PMID:
28431605
50.

Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease.

Bor R, Farkas K, Fábián A, Bálint A, Milassin Á, Rutka M, Matuz M, Nagy F, Szepes Z, Molnár T.

PLoS One. 2017 Mar 31;12(3):e0172916. doi: 10.1371/journal.pone.0172916. eCollection 2017.

Supplemental Content

Support Center